Since the drop out screen suggested a role for PSMC6 in survival of IGROV-1/Pt1 cells, we examined publicly available data set and found that PSMC6 expression was associated with reduced progression free survival of ovarian cancer patients, supporting the interest of further exploring its biological significance. Here, ZNF77 is linked to ovarian cancer.